PEOPLE - Nanyang Management makes appointment:
This article was originally published in Clinica
Executive Summary
Mike Hirshorn, one of Australia's most experienced medical technology commercialisation executives, has joined venture capital firm Nanyang Management. Mr Hirshorn is one of the founders of cochlear implant company Cochlear. He was also a founding director of sleep apnoea Nasdaq-listed Australian company Resmed and until recently was with Polartechnics, which is commercialising a cervical screening and melanoma detection device. With the addition of Mr Hirshorn, Nanyang, which manages St George Development Capital Fund and focuses on technology and specialised manufacturing, will also take an interest in medical devices.